Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
17/09/2025
Bank of America CEO Moynihan: The borrowing of commercial clients with credit limits still remains relatively low compared to the available credit limits.
Latest
3 m ago
Release of the Joint Action Plan for Promoting the Development of International Arbitration in the Digital Age
3 m ago
Beike-W (02423.HK) on September 16 spent $4.3268 million to repurchase 652,600 shares.
3 m ago
The Governor of the Bank of Canada, Macklem, said that we do need to consider the trend of inflation; inflation pressures seem to be more manageable.
4 m ago
Imperial Financial Group (08029.HK) plans to sell approximately 19.17% of its new shares at a maximum net raising of around 17.6 million Hong Kong dollars.
4 m ago
Novo Nordisk ADR is currently up 2.9%, while Pfizer, Eli Lilly, and pharmaceutical ETFs are up by at most 1.99% and the US pharmaceutical ETF is up 0.87%. Recent criticism from the US Food and Drug Administration (FDA) has caused the supplier of the affordable weight loss drug, Hims & Hers Health, to drop more than 2%.
See all latest